Your browser doesn't support javascript.
loading
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study.
van der Heijde, Désirée; Gensler, Lianne S; Maksymowych, Walter P; Landewé, Robert; Rudwaleit, Martin; Bauer, Lars; Kumke, Thomas; Kim, Mindy; Auteri, Simone Emanuele; Hoepken, Bengt; Deodhar, Atul.
Afiliación
  • van der Heijde D; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands mail@dvanderheijde.nl.
  • Gensler LS; Department of Medicine/Rheumatology, University of California San Francisco, San Francisco, California, USA.
  • Maksymowych WP; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Landewé R; Rheumatology Department, Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, The Netherlands.
  • Rudwaleit M; Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands.
  • Bauer L; Department of Internal Medicine and Rheumatology, University of Bielefeld, Bielefeld, Germany.
  • Kumke T; UCB Pharma, Monheim am Rhein, Germany.
  • Kim M; UCB Pharma, Monheim am Rhein, Germany.
  • Auteri SE; UCB Pharma, Smyrna, Georgia, USA.
  • Hoepken B; UCB Pharma, Milan, Italy.
  • Deodhar A; UCB Pharma, Monheim am Rhein, Germany.
RMD Open ; 8(1)2022 03.
Article en En | MEDLINE | ID: mdl-35296532

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Espondiloartritis / Sacroileítis / Espondiloartritis Axial Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: RMD Open Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Espondiloartritis / Sacroileítis / Espondiloartritis Axial Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: RMD Open Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos